NCT00495573View on ClinicalTrials.gov

HSV-2 Shedding Resolution After Acyclovir Treatment

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

March 31, 2012

Conditions
Genital Herpes
Interventions
DRUG

acyclovir

400 mg acyclovir, orally three times a day for 5 days

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Washington

OTHER

NCT00495573 - HSV-2 Shedding Resolution After Acyclovir Treatment | Biotech Hunter | Biotech Hunter